日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Investigating the Use of Pharmacogenetic and Pharmacometabolomic Markers to Predict Haloperidol Efficacy and Safety Rates

研究利用药物遗传学和药物代谢组学标志物预测氟哌啶醇的疗效和安全性

Skryabin, Valentin Yurievich; Zastrozhin, Mikhail Sergeevich; Parkhomenko, Aleksandra Aleksandrovna; Pankratenko, Ekaterina Petrovna; Pozdnyakov, Sergei Aleksandrovich; Denisenko, Natalia Pavlovna; Akmalova, Kristina Anatolyevna; Bryun, Evgeny Alekseevich; Sychev, Dmitry Alekseevich

Relationship of the 1846G > A Polymorphism of the CYP2D6 Gene to the Equilibrium Concentration Levels of Haloperidol in Patients with Acute Alcoholic Hallucinosis

CYP2D6基因1846G>A多态性与急性酒精性幻觉患者体内氟哌啶醇平衡浓度水平的关系

Parkhomenko, A A; Zastrozhin, M S; Skryabin, VYu; Petukhov, A E; Pozdniakov, S A; Ivanchenko, V A; Zaytsev, I A; Bure, I V; Bochkov, P O; Akmalova, K A; Smirnov, V V; Bryun, E A; Sychev, D A

Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis

CYP3A4*1B单核苷酸多态性与氟哌啶醇治疗急性酒精性幻觉症患者的疗效和安全性之间的关系

Parkhomenko, A A; Zastrozhin, M S; Skryabin, VYu; Petukhov, A E; Pozdniakov, S A; Ivanchenko, V A; Zaytsev, I A; Bure, I V; Bochkov, P O; Akmalova, K A; Smirnov, V V; Bryun, E A; Sychev, D A

Correlation of 1846G>A Polymorphism of CYP2D6 Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic Hallucinoses

CYP2D6基因1846G>A多态性与酒精性幻觉患者使用氟哌啶醇的疗效和安全性的相关性

Parkhomenko, A A; Zastrozhin, M S; Skryabin, VYu; Ivanchenko, V A; Pozdniakov, S A; Noskov, V V; Zaytsev, I A; Denisenko, N P; Akmalova, K A; Bryun, E A; Sychev, D A

Association of CYP2D6*4 Polymorphism with the Steady-State Concentration of Haloperidol in Patients with Alcohol-Induced Psychotic Disorders

CYP2D6*4多态性与酒精性精神病患者体内氟哌啶醇稳态浓度的相关性

Parkhomenko, A A; Zastrozhin, M S; Pozdnyakov, S A; Noskov, V V; Zaytsev, I A; Ivanchenko, V A; Denisenko, N P; Akmalova, K A; Skryabin, VYu; Bryun, E A; Sychev, D A